Atlas Trials

Helical Tomotherapy, Fludarabine Phosphate, and Melphalan Followed By Allo-HSCT in Hematological Malignancies

Clinical trial NCT00544466 · ACTIVE_NOT_RECRUITING

Trial details

NCT number
NCT00544466
Sponsor
City of Hope Medical Center
Status
ACTIVE_NOT_RECRUITING
Phase
Phase 1, Phase 2
Study type
INTERVENTIONAL
LeukemiaMyelodysplastic Syndromes
Start date
2006-07-31
Primary completion
2013-08-01
Enrollment
75

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.